ZN7-30923-37735
2 vaccinations
9 coded responses
24 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 235 / VA
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Dose 1 — Pfizer-BioNTech
-
2021-02-24
Registered in v-safe
-
2021-02-24
Survey response — days 1–6 daily, dose 1MedDRA: Injection site hypoaesthesia — Feeling: Good · Site: PainFree text: Very mild numbness around injection site yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-09
-
2021-03-16
Dose 2 — Pfizer-BioNTech
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased, Lymph node pain — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Elevated heart rate 30 bpm higher the last 2 days, sore lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Good · Site: PainFree text: Elevated heart rate 20 bpm above normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Good · Site: PainFree text: RHR 10 bpm above normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Good · Site: RednessFree text: RHR still 10 bpm above normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Good · Site: Pain, ItchingFree text: RHR still 10 bpm above normalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-30
-
2021-04-06
Survey response — day 21, dose 2MedDRA: Rash, Skin exfoliation — Feeling: GoodFree text: Developed a rash after receiving the second shot. Rash was in the location of the first shot. Rash peeled like a sunburn.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
- 2021-04-20
- 2021-04-27
-
2021-06-15
Survey response — 3 months, dose 2MedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme joint pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-14
Survey response — 6 months, dose 2MedDRA: Cartilage injury, Periarthritis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Frozen shoulder and posterior labral tear.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-17
- 2022-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-16 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-14 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Very mild numbness around injection site yesterday
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Elevated heart rate 30 bpm higher the last 2 days, sore lymph nodes
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Elevated heart rate 20 bpm above normal.
Systemic reaction (other): RHR 10 bpm above normal
Systemic reaction (other): RHR still 10 bpm above normal.
Systemic reaction (other): RHR still 10 bpm above normal
Release 7 — day 21, dose 2
Symptoms: Developed a rash after receiving the second shot. Rash was in the location of the first shot. Rash peeled like a sunburn.
Release 9 — 3 months, dose 2
Symptoms: Extreme joint pain.
Release 9 — 6 months, dose 2
Symptoms: Frozen shoulder and posterior labral tear.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cartilage injury | · | · | ✓ |
| SD | Periarthritis | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Skin exfoliation | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Injection site hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release